An international study focusing on the development of new treatments for methicillin-resistant Staphylococcus aureus has been stopped as a result of insufficient funds. The study was exploring the potential of a protein called calprotectin, which can inhibit MRSA's food source, as a treatment for the bacteria. The researchers hope their work will be revived in the future.

Related Summaries